Vir Biotechnology Inc. (VIR) Tops Q3 EPS by 172c

Vir Biotechnology Inc. (NASDAQ: VIR) reported Q3 EPS of $1.30, $1.72 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $374.6 million versus the consensus estimate of $146.35 million.

For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• AB Science reports phase 1 data for AB8939 plus venetoclax in AML
• JPMorgan Starts Graphic Packaging Holding Company (GPK) at Neutral